Ozone therapy in patients with chronic pelvic pain
Keywords:
ozone therapy, chronic pelvic pain, endometriosis, pelvic congestion.Abstract
Introduction: The feasibility and safety of the use of ozone therapy is evidenced in the results presented by several authors, in diseases whose main symptom is chronic pain.Objective: To determine the clinical evolution of patients with chronic pelvic pain treated with ozone associated with conventional medical treatment.
Methods: Descriptive, observational, retrospective study, in which the clinical evolution of patients with chronic pelvic pain treated from January 2018 to January 2020, with ozone therapy, associated with conventional medical treatment. The sample was 54 women. The variables used were: age, cause of pelvic pain, time of evolution, score on the pain scale before and after the application of ozone therapy, and evaluation of the treatment.
Results: Patients aged 26-35 years prevailed. 57,4 % had between two and four years of pain evolution. Chronic pelvic inflammatory disease was the most frequent cause with 42,5 %. Before the application of ozone therapy, the mean score on the pain scale was 6.31, and it decreased to 3 after treatment, with an evaluation of good in 81,1 % of the cases.
Conclusions: After the application of ozone therapy associated with conventional medical treatment, there is evident clinical improvement, which is why it constitutes an alternative of treatment.
Downloads
References
2. Schwartz Adriana. Ozonoterapia y Pseudociencia. Revista Española de Ozonoterapia. 2018 [acceso: 19/01/2021]; 8(1): 1-3. Disponible en: https://www.revistaespañoladeozonoterapia.es/index.php/reo/article/view/122/121
3. Borrego Díaz R, González Sapsín K, Pérez Mesa JC. Evaluación clínica del tratamiento con ozono en las hernias discales. Centro Oncológico Territorial Holguín. Año 2017. Correo Científico Médico. 2020 [acceso: 19/01/2021]; 24(1): [7 p.]. Disponible en: https://www.revcocmed.sld.cu/index.php/cocmed/article/view/3184
4. Urgellés Carreras S, Aguilar Aleaga L, Reyes Guerrero E, Álvarez Fiallo M. Uso de ozonoterapia en las pacientes con enfermedad inflamatoria pélvica aguda Etapa III. Revista Cubana de Obstetricia y Ginecología. 2019 [acceso: 19/01/2021];45(3):e480. Disponible en: https://www.revginecobstetricia.sld.cu/index.php/gin/article/view/480/399
5. Rivera-Soto MA. Tratamiento con Ozonoterapia Médica vía Insuflación Vaginal, en paciente femenina mexicana infectada con VPH 16,18. Reporte de caso. Revista Española de Ozonoterapia. 2017 [acceso: 19/01/2021];7(1): 111-120.Disponible en: https://www.revistaespañoladeozonoterapia.es/index.php/reo/article/view/120
6. Arenas Falcón B, Calunga Fernández JL, Menéndez Cepero S, Vera Yoshimoto C. La ozonoterapia y su aplicación en relación con la fisiopatología de la enfermedad COVID 19 Rev Panorama Cuba y Salud. 2020 [acceso: 19/02/2021]; 15(3):104-107. Disponible en: https://www.revpanorama.sld.cu/index.php/rpan/article/view/
7. Samper Bernal D. El paradigma del ozono en el tratamiento del dolor. Revista de la sociedad española del dolor. 2020 [acceso: 22/02/2021];27(2): [2 p.]. Disponible en: https://www.resed.es/Documentos/HTML/2020_27_2/3807ESP/01_69_71_ed_esp.html
8. García García LA, Trejos Hernández J, Poveda Rodríguez CA, Villegas Sequiera LR, Marchena Vásquez E, González Castro D. Causas ginecológicas de dolor pélvico crónico. Revista Médica de Costa Rica y Centroamérica. 2016[acceso: 19/1/2021];(620): 561- 564. Disponible en: https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2016/rmc163aa.pdf
9. Vasallo Comendeiro VJ, Arjona Fonseca S, Fernández Romaguera Y, Rondón Acosta J, Quevedo Álvarez L. Dolor pélvico crónico en la mujer. Rev Cub Anestesiol Reanim. 2014 [acceso: 24/1/2021]; 13(1):6-14. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1726-67182014000100003&lng=es
10. Wedel Herrera K. Dolor pélvico crónico. Revista Sinergia. 2018 [acceso: 25/1/2021];3(5): 3-8. Disponible en: https://www.medigraphic.com/pdfs/sinergia/rms-2018/rms185a.pdf
11. Menassa de Lucia Alejandra MD. Ozonoterapia en el abordaje integrativo del síndrome premenstrual. Reporte de casos. Ozone Therapy Global Journal. 2020[acceso:25/1/2021]; 10(1): 79-110. Disponible en: https://www.revistaespañoladeozonoterapia.es/index.php/reo/article/view/204
12. Vicente Herrero M, Delgado Bueno S, Bandrés Moyá F, Ramírez Iñiguez de la Torre M, Capdevila García L. Valoración del dolor. Revisión comparativa de escalas y cuestionarios. Rev Soc Esp Dolor. 2018 [acceso:25/6/2021]; 25(4): 228-236. Disponible en: https://scielo.isciii.es/pdf/dolor/v25n4/1134-8046-dolor-25-04-00228.pdf
13. Asociación Médica Mundial (AMM). Declaración de Helsinki de la AMM: Principios éticos para las investigaciones médicas en seres humanos. Brasil, Fortaleza: 64ª Asamblea General AMM. 2013 [acceso:18/04/2020]. Disponible en: https://repositorio.mederi.com.co/bitstream/handle/123456789/386/-Declaracion-Helsinki-2013-Esp.pdf?sequence=1
14. Cuba Rodríguez LC, Rojas Carmenaty S, Castellanos Bertot Y, Cardosa Valladares Y. Ozonoterapia paravertebral en la patología de la columna vertebral lumbar. Rev. Inf. Cient. 2019 [acceso: 25/1/2021];98(3):364-373. Disponible en: https://scielo.sld.cu/scielo.php?pid=S1028-9332019000300364&script=sci_abstract&tlng=pt
15. Jynani Pichara M, Roberta Tim C,Assis L. Considerações Sobre O Uso Da Ozonioterapia (O3) No Tratamento De Endometriose. Research, Society and Development. 2020 [acceso: 22/2/2021]; 9(9):1-21. Disponible en: https://rsdjournal.org/index.php/rsd/article/view/7616/6568
16. Ruiz Reyes D, Romo Elena M. Ozonoterapia en patologías de columna: Revisión de casos. Bionatura.2017[acceso: 22/2/2021]; 2(2): 312-316. Disponible en: https://www.revistabionatura-.com/files/2017.02.02.7.pdf
Published
How to Cite
Issue
Section
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.